Takahiko Horiuchi
Ehime University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Takahiko Horiuchi.
Human Genetics | 1994
Takahiko Horiuchi; Nobuaki Hatta; Mitsuru Matsumoto; Hisashi Ohtsuka; Francis S. Collins; Yuzuru Kobayashi; Shigeru Fujita
We report two familial cases of NF1 presenting as C to T transitions changing an Arg-1947 codon to a stop codon. In one of the two families, cosegregation of the mutation with NF1 was demonstrated, indicating this mutation causes the disease in this family. As the same mutation at Arg-1947 has been reported previously in three cases of unrelated Caucasians (two are sporadic; the origin of the other is not reported), the codon at Arg-1947 (CGA) in the NF1 gene is considered to be a hotspot common among different ethnic groups and also among familial and sporadic cases.
Acta Haematologica | 1993
Takahiko Horiuchi; Masaki Yasukawa; Kohsuke Yanagisawa; Takaaki Hato; Shigeru Fujita
Immunological analysis of 2 cases of granular lymphocyte proliferative disorder with clonal expansion of CD3+4”8+ T cells bearing either T cell receptor α/β (patient 1) or T cell receptor γ/δ (patient 2) is reported. Significant cyto-toxic activity against K562 was observed in peripheral blood mononuclear cells (PBMC) isolated from patient 2, but not in PBMC from patient 1, although the cytotoxic activity of patient 1 could be augmented following incubation with anti-CD3 monoclonal antibody (MoAb). Northern blot analysis revealed that perforin mRNA was expressed in both patients. Proliferative response to phy-tohemagglutinin, anti-CD3 MoAb and 12-0-tetradecanoylphorbol-13-acetate was low in PBMC from both patients compared to that from healthy controls. Cytoplasmic free calcium of PBMC from the 2 patients increased similarly to that of healthy controls after treatment with anti-CD3 MoAb.
Cancer | 1994
Mitsuru Matsumoto; Kiyonori Takada; Takaaki Hato; Takahiko Horiuchi; Masaki Yasukawa; Shinichi Murao; Shigeru Fujita
Expression of CD4 or CD8 on the cell surface is an important guide for discriminating the immunologic functions of T‐cells. However, a minor T‐cell subset lacking both CD4 and CD8 molecules but bearing the usual form of T‐cell receptor (TCR)‐αβ (CD4−CD8−TCR‐αβ+ T‐cells) has recently been found not only in mice but also in humans, and the clinical relevance of this newly defined subpopulation to human diseases is now of considerable interest. The authors present a patient in whom CD4−CD8−TCR‐αβ+ T‐cells showed monoclonal proliferation in the peripheral blood for more than 3 years, then disappeared spontaneously, followed by subsequent development of Hodgkins disease. The pathologic roles of double‐negative T‐cell proliferation in this case are discussed from the viewpoint of premalignancy in lymphoproliferative diseases. Cancer 1994; 73:2818–23.
Acta Haematologica | 1994
Kohsuke Yanagisawa; Kyouko Kishimoto; Takahiko Horiuchi; Kiyonori Takada; Masaki Yasukawa; Shigeru Fujita
We examined the effects of interleukin-4 (IL-4) on the growth of hematopoietic precursors from a patient with chronic myelomonocytic leukemia (CMMoL). In the chronic phase of the disease, IL-4 inhibited spontaneous colony formation by CMMoL cells in semi-solid culture. However, in the acute phase, IL-4 promoted colony formation. These effects of IL-4 were abolished completely by the addition of anti-IL-4 neutralizing antibodies. The spontaneous colony formation by CMMoL cells in both the chronic and acute phases was inhibited by the addition of anti-IL-6 antibodies. On the other hand, neither anti-IL-6, anti-granulocyte macrophage colony-stimulating factor (GM-CSF), anti-IL-1 beta nor anti-tumor necrosis factor alpha (TNF alpha) antibodies inhibited IL-4-induced colony formation by CMMoL cells in the acute phase. IL-4 suppressed the production of IL-6 by CMMoL cells in both the chronic and acute phases. These results suggest that in the present patient, IL-4 suppressed the IL-6-mediated autocrine growth of CMMoL cells in both the chronic and acute phases, but directly stimulated their growth in the acute phase.
Preventive Medicine | 1992
Hirota Fujiki; Seiji Yoshizawa; Takahiko Horiuchi; Masami Suganuma; Jun Yatsunami; Shinji Nishiwaki; Sachiko Okabe; Rie Nishiwaki-Matsushima; Takuo Okuda; Takashi Sugimura
Japanese Journal of Cancer Research | 1987
Takahiko Horiuchi; Hirota Fujiki; Mitsuru Hirota; Maitree Suttajit; Masami Suganuma; Akiko Yoshioka; Vichai Wongchai; Erich Hecker; Takashi Sugimura
Microbial Pathogenesis | 1996
Mitsuru Matsumoto; Yoshiki Tange; Takanori Okada; Yasuhiro Inoue; Takahiko Horiuchi; Yuzuru Kobayashi; Shigeru Fujita
Biochemical and Biophysical Research Communications | 1994
Nobuaki Hatta; Takahiko Horiuchi; Shigeru Fujita
Biochemical Journal | 1995
Ichiro Watanabe; Takahiko Horiuchi; Shigeru Fujita
Archive | 2013
Kouko Sakai; Kenshi Hayashi; Chinami Hashimura; Yoshiyuki Niho; Peter M. Schneider; Shoichi Inaba; Takahiko Horiuchi; Hiroaki Nishizaka; Takeshi Kojima